Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Dalgas, U.
Right arrow Articles by Ingemann-Hansen, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalgas, U.
Right arrow Articles by Ingemann-Hansen, T.
Related Collections
Right arrow All Rehabilitation
Right arrow Class III
Right arrow All Demyelinating disease (CNS)
Right arrow Multiple sclerosis
NEUROLOGY 2009;73:1478-1484
© 2009 American Academy of Neurology

Resistance training improves muscle strength and functional capacity in multiple sclerosis

U. Dalgas, PhD, E. Stenager, MD, J. Jakobsen, MD, T. Petersen, MD, H. J. Hansen, MD, C. Knudsen, PT, K. Overgaard, PhD and T. Ingemann-Hansen, MD

From the Department of Sport Science (U.D., C.K., K.O., T.I.-H.), University of Aarhus; Department of Neurology (U.D., E.S.), Soenderborg Hospital; and Department of Neurology (U.D., J.J., T.P., H.J.H.), Aarhus University Hospital, Denmark.

Address correspondence and reprint requests to Ulrik Dalgas, Department of Sport Science, University of Aarhus, Dalgas Ave. 4, 8000 Aarhus C, Denmark dalgas{at}sport.au.dk

Objective: To test the hypothesis that lower extremity progressive resistance training (PRT) can improve muscle strength and functional capacity in patients with multiple sclerosis (MS) and to evaluate whether the improvements are maintained after the trial.

Methods: The present study was a 2-arm, 12-week, randomized controlled trial including a poststudy follow-up period of 12 weeks. Thirty-eight moderately impaired patients with MS were randomized to a PRT exercise group (n = 19) or a control group (n = 19). The exercise group completed a biweekly 12-week lower extremity PRT program and was afterward encouraged to continue training. After the trial, the control group completed the PRT intervention. Both groups were tested before and after 12 weeks of the trial and at 24 weeks (follow-up), where isometric muscle strength of the knee extensors (KE MVC) and functional capacity (FS; combined score of 4 tests) were evaluated.

Results: KE MVC and FS improved after 12 weeks of PRT in the exercise group (KE MVC: 15.7% [95% confidence interval 4.3–27.0], FS: 21.5% [95% confidence interval 17.0–26.1]; p < 0.05), and the improvements were better than in the control group (p < 0.05). The improvements of KE and FS in the exercise group persisted at follow-up after 24 weeks. Also, the exercise effects were reproduced in the control group during the 12-week posttrial PRT period.

Conclusions: Twelve weeks of intense progressive resistance training of the lower extremities leads to improvements of muscle strength and functional capacity in patients with multiple sclerosis, the effects persisting after 12 weeks of self-guided physical activity.

Level of evidence: The present study provides level III evidence supporting the hypothesis that lower extremity progressive resistance training can improve muscle strength and functional capacity in patients with multiple sclerosis.

Abbreviations: 10MWT = 10-m walk test; 6MWT = 6-minute walk test; CI = confidence interval; CST = chair stand test; EDSS = Expanded Disability Status Score; FS = functional capacity score; KE MVC = maximum voluntary contraction of the knee extensors; KF MVC = maximum voluntary contraction of the knee flexors; MS = multiple sclerosis; NS = not significant; PRT = progressive resistance training; RCT = randomized controlled trial; RM = repetition maximum; SCT = stair-climbing test.


Supported by the National Multiple Sclerosis Society, The Research Foundation of the MS Clinic of Southern Denmark (Vejle, Esbjerg, and Soenderborg), Director Werner Richter and Wife's Grant, The Augustinus-Foundation, Engineer Bent Boegh and Wife Inge Boeghs Foundation, Vilhelm Bangs Foundation, Manufacturer Mads Clausen's Foundation, The Toyota Foundation, Mrs. Benthine Lund's Foundation, and AP Moeller's Foundation.

Disclosure: Author disclosures are provided at the end of the article.

Received February 11, 2009. Accepted in final form July 21, 2009.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by AAN Enterprises, Inc.